Uterine Artery Embolization Versus Hysterectomy in the Treatment of Symptomatic Adenomyosis: Protocol for the Randomized QUESTA Trial.
de Bruijn AM, Lohle PN, Huirne JA, de Vries J, Twisk M; QUESTA-Trial Group, Hehenkamp WJ. JMIR Res Protoc. 2018 Mar 1;7(3)
Pre-treatment with GnRHa or ulipristal acetate prior to laparoscopic and laparotomic Myomectomy: A systematic review and meta-analysis.
de Milliano I, Twisk M, Ket JC, Huirne JA, Hehenkamp WJ. PLoS One. 2017 Oct 16;12(10)
The SUPER study: protocol for a randomised controlled trial comparing follicle-stimulating hormone and clomiphene citrate for ovarian stimulation in intrauterine insemination.
Danhof NA, van Wely M, Koks CAM, Gianotten J, de Bruin JP, Cohlen BJ, van der Ham DP, Klijn NF, van Hooff MHA, Broekmans FJM, Fleischer K, Janssen CAH, Rijn van Weert JM, van Disseldorp J, Twisk M, Traas M, Verberg MFG, Pelinck MJ, Visser J, Perquin DAM, Boks DES, Verhoeve HR, van Heteren CF, Mol BWJ, Repping S, van der Veen F, Mochtar MH. BMJ Open. 2017 May 25;7(5)
The usefulness of evaluating effectiveness: pre-implantation genetic screening as an example.
Twisk M. Ned Tijdschr Geneeskd. 2012;156(5)
Preimplantation genetic screening: a systematic review and meta-analysis of RCTs.
Mastenbroek S, Twisk M, van der Veen F, Repping S. Hum Reprod Update. 2011 Jul-Aug;17(4):454-66
Perspectives of couples with high risk of transmitting genetic disorders.
Musters AM, Twisk M, Leschot NJ, Oosterwijk C, Korevaar JC, Repping S, van der Veen F, Goddijn M. Fertil Steril. 2010 Sep;94(4):1239-43
What next for preimplantation genetic screening? More randomized controlled trials needed?
Mastenbroek S, Scriven P, Twisk M, Viville S, Van der Veen F, Repping S. Hum Reprod. 2008 Dec;23(12):2626-8
In Vitro Fertilization with Preimplantation Genetic Screening In Women Of Advanced Maternal Age. Mastenbroek S., Twisk M., van Echten-Arends J., Sikkema-Raddatz B., Korevaar J.C., Verhoeve H.R., Vogel N.E.A., Arts E.G.J.M., de Vries J.W.A., Bossuyt P.M., Buys C.H.C.M., Heineman M.J., Repping S.,vander Veen F. N.Engl. J.Med. 2007, 357(1); 9-17
Preimplantation genetic screening as an alternative to prenatal testing for Down syndrome: preferences of women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment.
Twisk M., Haadsma M.L., van der Veen F., Repping S., Mastenbroek S., Heineman M.J., Bossuyt P.M., Korevaar J.C. Fertil. Steril. 2007, 88(4); 804-10
Preferences of subfertile women regarding elective single embryo transfer: Additional in vitro fertilization cycles are acceptable, lower pregnancy rates are not.
Twisk M., van der Veen F., Repping S., Heineman M.J., Korevaar J.C., Bossuyt P.M Fertil. Steril. 2007, 88(4); 1006-9
Is twin pregnancy necessarily an adverse outcome of assisted reproductive technologies?
van Wely M., Twisk M., Mol B.W.J., van der Veen F. Human Reprod. 2006; 21; 2736-8
Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection.
Twisk M., Mastenbroek S., van Wely M., Heineman M.J., van der Veen F., Repping S. The Cochrane Database of Systematic Reviews 2006, Issue 1
Chyleus ascites; a remarkable presentation of an ovarium malignancy (article in Dutch).
Twisk M., Bijvoet S.M., Loffeld R.P.L.F., Doornbos J.D. NTOG, december 2003
Colonisation density and topographic localisation of Helicobacter pylori do not depend on the CagA status.
Twisk M., Kusters J.G., Balk A.G., Kuipers E.J., Loffeld R.J.L.F. Journal of Clinical Pathology 2001; 54;771-3